The Director General for the newly created National Agency for Healthcare Equipment and Management of Health…

Save Share

Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and…

Save Share

The top 10 most-read interviews on PharmaBoardroom in 2020 represents the broad geographic scope we have had in the…

Save Share

Dr Remo Gujer gives an overview of the BMS footprint in Switzerland and Austria, the ongoing integration of legacy…

Save Share

Brad Campbell, president and COO of US rare disease specialist Amicus, talks domestic and global product launches,…

Save Share

Hours after President Biden was inaugurated on Tuesday 19th January 2021, Dr Janet Woodcock was named as acting…

Save Share

Alessandro Riva, MD joined biotech Ichnos Sciences as its founding CEO in 2019, leaving behind a storied career in…

Save Share

COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in…

Save Share

With upcoming EU regulation poised to have a massive impact on ethical regulations around AI in Europe, Bayer Head…

Save Share

Clinerion, a leader in real-world data solutions, is helping bring medical data informatics to the life sciences…

Save Share

David H. Crean, managing director for Objective Capital Partners, provides insights on US innovation and long term…

Save Share

Kevin Rufang Huang, president and founder of the Chinese Organization for Rare Disorders (CORD), outlines the…

Save Share

Following on from our list of the overall top 10 companies in the Saudi Arabian pharma market, here PharmaBoardroom…

Save Share

The collaboration between BioNTech and Pfizer on a COVID-19 vaccine candidate based on mRNA technology continues…

Save Share

The latest from Spanish pharma, including the wide swathe of COVID-19 syringes, vaccines, masks, and tests being…

Save Share

While cell and gene therapies are all the rage now, a little known fact is that the world’s first approved gene…

Save Share

Sissel Lønning Andresen explains how Pfizer Norway has been a pioneer of digital communication channels for years,…

Save Share

Roche Diagnostics Norway’s Daniel Malarek discusses the resurgence of diagnostics in the wake of the COVID-19…

Save Share

Prof Dr Jürg Utzinger of the Swiss Tropical and Public Health Institute (Swiss TPH) outlines the organisation’s…

Save Share

David H. Crean summarizes the recent 39th annual J.P. Morgan Healthcare Conference 2021 that was held in a virtual…

Save Share

Dr Chris Martin, CEO and co-founder of Swiss-headquartered antibody-drug conjugate cancer company, ADC…

Save Share

Sanofi CEO Paul Hudson ignited a heated debate around vaccine nationalism earlier this year when he suggested that…

Save Share

The latest news from Indian pharma, including a 200 percent boost for the country’s pharmaceutical industry in…

Save Share

With Rare Disease Day falling on 28 February, PharmaBoardroom dedicates this month to exploring the global rare…

Save Share

Joe Lewis outlines the key concerns of Deloitte’s pharma clients around manufacturing and supply chain operations…

Save Share

In a recent conversation with PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug…

Save Share

Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative…

Save Share

A roundup of some of the most important recent news from German pharma, including state honours for the founders of…

Save Share

Redalpine Venture Partners’ Dr Michael Sidler highlights some of the key trends in the European biotech VC…

Save Share

In his latest piece on Alzheimer’s Disease (AD) drug Aducanumab’s winding journey to market, Dr Neil Cashman…

Save Share

Marcel Plattner, president of Swiss industry association vips discusses pricing, market access and innovation, as…

Save Share

A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…

Save Share

DHL’s Larry St Onge outlines how the logistics giant adapted to the COVID-19 pandemic in 2020, the unprecedented…

Save Share

Dan Leonard, president and CEO of the Association for Accessible Medicines (AAM) since August 2020, outlines his…

Save Share

A rundown of five things to know about the USD 8.2 billion Saudi pharma market, including the impact of ‘Vision…

Save Share

The latest from healthcare and the life sciences in Latin America, including the most recent wave of Indian pharma…

Save Share

Alfasigma Switzerland’s Dr Tytus Litynski introduces the Italian firm’s diversified portfolio of both Rx drugs…

Save Share

Eric ten Kate, VP for Global Life Science at logistics and distribution firm Agility, highlights how the company…

Save Share

The latest from Italian pharma, including the foreign minister’s plea for delivering on COVID-19 vaccine…

Save Share

The latest LatAm pharma news, including COVID-19 vaccine rollouts in Colombia, Brazil, and Mexico as well as legal…

Save Share

On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…

Save Share

Niklas Hedberg outlines the role of EUnetHTA as both a network and project built up of national HTAs in Europe, the…

Save Share

Christian Probst gives an overview of GSK Norway’s broad portfolio, market access hurdles, and the importance of…

Save Share

Pius Zängerle of curafutura, one of the two largest Swiss health insurers’ associations, explains the unique…

Save Share

Mera Pharma’s Khalid Saleh introduces the Swiss-headquartered but MENA-focused company, how it plans to expand…

Save Share

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park looks at how a technology developed in Japan…

Save Share

Dan Schneider discusses the continuing Norwegian identity of Photocure, despite its increasingly global footprint,…

Save Share

The latest news from Russian pharma, including Biocad’s ramping up of Sputnik V COVID-19 vaccine manufacturing,…

Save Share

A roundup of the latest from Chinese pharma, including Green Valley’s upcoming US trial for an…

Save Share

The EMA’s Head of Advanced Therapies Dr Ana Hidalgo-Simon outlines Europe’s evolving regulatory framework for…

Save Share

The latest news from Russian pharma and healthcare including a big funding injection for primary care up to 2025,…

Save Share

Pierrre Morneau of Takeda Switzerland explains the therapeutic areas at the core of the company, equitable access,…

Save Share

Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player…

Save Share

CEO Ellen Cathrine Andersen introduces Norwegian firm Epiguard’s ‘Epishuttle’ technology for transporting…

Save Share

Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and…

Save Share

RemeGen, a low-profile Chinese biotech company based in Yantai city in the coastal Shandong province, around nine…

Save Share

Rubens Hannun, president of the Arab Brazilian Chamber of Commerce, discusses the commercial relationship between…

Save Share

Market access and pricing expert Barbara Jaszewski outlines the issues inherent in the USA importing drugs from…

Save Share

AbbVie Switzerland’s Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office…

Save Share

In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association…

Save Share

ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals…

Save Share

This article forms part of Healthcare & Life Sciences Review: Switzerland February 2021, a comprehensive…

Save Share

Professor Nicolaus Kröger, president of the European Society for Blood and Marrow Transplantation (EBMT)…

Save Share

Clint Sharples, CEO of Heritage Cannabis, gives a potted history of the medical cannabis industry in Canada, its…

Save Share

When Abdi Ibrahim acquired a 28.5 percent stake in Swiss biotech OM Pharma in September 2020, it represented a…

Save Share

Although Switzerland is ahead of many of its competitors in Europe on levels of healthcare innovation, one…

Save Share

Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights…

Save Share

hystrix medical is an online contracting marketplace for medical devices and replenishing/repeat purchase products…

Save Share

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…

Save Share

The story of how British doctor Edward Jenner serendipitously discovered a way to inoculate people against smallpox…

Save Share

One of the largest domestic pharma companies in China (ranking number one from 2014 to 2019), Yangtze River…

Save Share

While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…

Save Share

2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…

Save Share

Following a recent capital injection of USD 67 million, Chinese biotech EdiGene is set to advance its pipeline in…

Save Share

Dr Liang Schweizer introduces immunotherapy-focused biotech HiFiBiO Therapeutics, the main advantages of the…

Save Share

Merck VP for Global Market Access & Pricing Strategic Planning Marco Rauland examines the trend of…

Save Share

Dr Gideon Ho, co-founder and CEO of HistoIndex, shares the story of the company’s establishment in 2010, their…

Save Share

Following on from our profile on five of the most promising clinical-stage biotech companies developing orphan…

Save Share

Biotech veteran Brian O’Callaghan introduces ObsEva – a Swiss-based firm focused on women’s health –, his…

Save Share

The latest news from pharma and healthcare in Latin America, including funding and logistics challenges in national…

Save Share

Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical…

Save Share

Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known…

Save Share

HiFiBiO Therapeutics cofounder, CEO and CSO Dr Liang Schweizer fits the profile of a Chinese biotech CEO to a T:…

Save Share

The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in…

Save Share

On 15 November 2020, the world’s largest trade deal in terms of GDP – the Regional Comprehensive Economic…

Save Share

Advances in cell and gene therapies (CGT) are credited with thoroughly transforming medicinal science and creating…

Save Share

The CEO & President of CDMO CordenPharma, Dr Michael Quirmbach, delves into the contract manufacturing…

Save Share

Small in terms of market size and without the historic life sciences footprint of neighbouring Sweden and Denmark,…

Save Share

With several COVID-19 vaccines gaining regulatory approval across the world in record time, a spotlight has been…

Save Share

Laurent Massuyeau introduces Swiss biosimilar commercialisation specialist iQone healthcare, why it made sense to…

Save Share

In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and…

Save Share

Alejandro Mora, Ferrer’s country manager for Central America & Caribbean, discusses the complexity of the…

Save Share

Dennis Hens, the Dutch CEO of Norwegian neuro-opthalmology device player Bulbitech, outlines the company’s…

Save Share

The latest from Mexico’s fight against COVID-19, including news of vaccine tourism into the US, how China’s…

Save Share

Dr Valters Bolevics, director general of the Association of International Research-based Pharmaceuticals…

Save Share

Scientists have come together in an unparalleled worldwide collaboration and sharing of data to advance a COVID-19…

Save Share

Stephen J. Ubl, president and CEO of PhRMA, outlines the unprecedented collaboration and speed with which the…

Save Share

Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist…

Save Share

MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the…

Save Share

The Top 15 pharmaceutical companies in the Central America and Caribbean (CENCA) market list is dominated by…

Save Share

Bayer’s Michael Levy casts his eye over the implications of the advent of cell and gene therapies on…

Save Share

Merck Healthcare’s newly appointed Global Head of Business innovation, Renée C. Amundsen, highlights the…

Save Share

PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the…

Save Share

Andrea Emilio Rizzoli of the Dalle Molle Institute for Artificial Intelligence, among the top 10 in the world in…

Save Share

While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive,…

Save Share

Dr Ann Aerts, head of the Novartis Foundation, highlights how the COVID-19 crisis has thrust artificial…

Save Share

The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how…

Save Share

A roundup of the latest from the Middle East & Africa region, including Turkey’s debt to US pharma; deals…

Save Share

Genald Senior, general manager for Leterago, the leading pharma distributor in the Dominican Republic, discusses…

Save Share

Writing in the March edition of DIA’s Global Forum magazine, EMD Serono’s Ana Padua outlines the findings…

Save Share

Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment…

Save Share

Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…

Save Share

Alan Knox of Primex Pharmaceuticals explains how the COVID-19 pandemic has thrust the anaesthesia field back into…

Save Share

AAM President Dan Leonard highlights the findings of the association’s most recent report and re-states the value…

Save Share

Since China first announced its ground-breaking volume-based procurement (VBP) pilot program to reduce drug…

Save Share

While perhaps not as lucrative or – prior to COVID-19 – as attention-grabbing – as other areas of the…

Save Share

A roundup of some of the most important recent stories from Italian pharma, including an in-depth interview with…

Save Share

Thomas Bohn outlines how the life sciences industry in Western Switzerland has continued to perform well despite…

Save Share

The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar have on US healthcare today and…

Save Share

Last Wednesday, the lower chamber of the Mexican Congress approved a bill that would legalise recreational…

Save Share

2020 was a challenging year globally, but one in which the importance of the healthcare and life sciences sector…

Save Share

With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology…

Save Share

Pharma industry insiders view vaccines as one of the most challenging products to manufacture, fundamentally due to…

Save Share

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…

Save Share

Filip Standaert outlines the significance of the Nordic cluster to J&J’s medical device operations in Europe,…

Save Share

Alvotech – the biosimilars arm of Icelandic-headquartered generics player Alvogen – is positioning itself for…

Save Share

Dr Johan Van Hoof, global therapeutic area head of vaccines for Janssen, shares his extensive career experience in…

Save Share

As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last…

Save Share

Six of the top ten companies in the Brazilian pharma market are domestic.* Read on for an introduction to some of…

Save Share

Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression…

Save Share

Brent Ragans of Ferring Pharmaceuticals US discusses the effects of the COVID-19 pandemic on the company’s…

Save Share

Dr Haijun Dong, recently appointed CEO of BioDuro-Sundia, shares his priorities for the newly merged entity, one of…

Save Share

Emerging cell and gene therapies herald immense clinical value for patients, society, and healthcare systems:…

Save Share

Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s…

Save Share

Tatsuya Kaihara, head of US operations for Japanese eyecare specialist Santen, describes his excitement at bringing…

Save Share

The latest from Chinese pharma, including a new deal between AstraZeneca and Junshi Biosciences; Innoforce and…

Save Share

PhRMA’s Stephen J. Ubl outlines two ways in which the new US presidency can help lower healthcare costs and why…

Save Share

Many countries have struggled to adapt to the shift to remote working and digital communication brought about by…

Save Share

Sandoz Switzerland’s Jan Tangermann highlights the importance of the Swiss affiliate to the global group and how…

Save Share

South African firm Aspen has inked a deal with Johnson & Johnson for the technical transfer and proposed…

Save Share

Although the COVID-19 pandemic and the subsequent rush to develop diagnostics, therapeutics, and vaccines dominated…

Save Share

German biotech BioNTech has been thrust into the global spotlight thanks to its collaboration with global giant…

Save Share

Novartis Oncology’s Emanuele Ostuni (lead author) and Karin Blumer draw on their experience commercialising CAR-T…

Save Share

Dr Nicolas Fischer introduces Light Chain Bioscience, a Swiss biotech company focusing on the discovery and…

Save Share

Pfizer Switzerland’s Sabine Bruckner discusses Switzerland’s historic and continuing importance to Pfizer,…

Save Share

AbbVie Norway’s Kirsti Nyhus discusses access challenges in the Norwegian market for innovative drugs, the…

Save Share

The US heads for three leading international mid-cap innovators – Japanese firms Eisai and Kyowa Kirin and Danish…

Save Share

Singapore’s Institute of Mental Health offers a comprehensive range of psychiatric, rehabilitative, and…

Save Share

The EFPIA’s Nathalie Moll outlines the significance of Europe’s Beating Cancer Plan to cancer patients in…

Save Share

A trained physician with several years of practice under her belt, Katharina Gasser then moved into clinical…

Save Share

After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness…

Save Share

The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region, including the fallout from…

Save Share

Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…

Save Share

The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the…

Save Share

Belgian champion UCB’s global manufacturing head, Jacques Marbehant, talks candidly about managing a broad…

Save Share

One of the more intriguing aspects about the new wave of cell and gene therapies (CGT) coming onstream is that they…

Save Share

Dipharma SA is a Swiss specialty pharmaceutical company, developing improved generics medicines for rare metabolic…

Save Share

The Association of Representatives, Agents and Pharmaceutical Producers (ARAPF), represents 65 companies in the…

Save Share

After an illustrious career in oncology R&D, contributing greatly to the development of cutting-edge cancer…

Save Share

Professor Susan M. Gasser, now director and group leader emeritus of the Friedrich Miescher Institute for…

Save Share

Japanese medtech player Terumo’s APAC lead Probir Das outlines the company’s 100-year commitment to innovation,…

Save Share

CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio…

Save Share

The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…

Save Share

Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory…

Save Share

In an exclusive interview, Jean-Paul Clozel explains Idorsia’s unique value proposition as a biotech focused…

Save Share

Innosuisse CEO Annalise Eggimann presents the organisation’s renewed mandate as the main Swiss innovation…

Save Share

The global rush to secure access to COVID-19 vaccines has led to accusations that richer countries are hoarding…

Save Share

Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare…

Save Share

The latest from Southeast Asian pharma, including soaring output in Singapore, tax breaks for research in…

Save Share

After five years with Takeda heading up the Japan-headquartered pharma company’s US business, following the…

Save Share

While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally,…

Save Share

Founded by Toyoji Naito in December 1941, in just under 80 years, Eisai has become a leading global biopharma…

Save Share

Epidemiologist John-Arne Røttingen has had a long and distinguished career in both academia and industry,…

Save Share

Charles Chen of Taiwanese firm Medigen Vaccines Biologics Corp (MVC) shares his career journey, the company’s…

Save Share

Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to…

Save Share

Norway has long held a strong international position in neuroscience and is home to Professors May-Britt and Edvard…

Save Share

A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…

Save Share

After 15 years as director at the Friedrich Miescher Institute for Biomedical Research (FMI) (2004-2019) and even…

Save Share

Equality has long been a deeply held ideal in Norway, where the concept of allemannsretten – the legal right to…

Save Share

As the most important pharma hub in its region, and one of the most important globally, many companies look to…

Save Share

Thomas F. Schmidt, country manager of Roche Pharma in its home market of Switzerland discusses adjusting to his…

Save Share

During the FT Global Pharmaceutical and Biotechnology Conference earlier this week, four Big Pharma and biotech…

Save Share

Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the…

Save Share

COVID-19 has drawn global attention to the sorry state of funding and R&D investment in vaccine development and…

Save Share

Genomic medicine expert Professor Thomas D. Szucs explains what ignited his interest in the field and how payers…

Save Share

Ipsen CEO David Loew took aim at the lip service often paid to the notion of ‘patient-centricity’ in pharma in…

Save Share

The ascent of cell and gene therapies (CGT) is commonly regarded as one of the momentous turning points in the…

Save Share

At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine…

Save Share

Bayer’s Dr Vincent Ruland highlights his career trajectory from medical doctor to pharma country manager; the…

Save Share

Writing in the February edition of DIA’s Global Forum magazine, Thomas Kühler of Sanofi R&D looks at the…

Save Share

Speaking exclusively to PharmaBoardroom, Prof. Hisham Bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority…

Save Share

The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of…

Save Share

Bandar Reda outlines the evolution of the trading relationship between the UK and the Arab world, the role of the…

Save Share

The SGC’s Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance…

Save Share

After a transformative 2020, Shawview Consulting’s Brendan Shaw looks into his crystal ball and makes five…

Save Share

Rare disease patient advocate Monica Weldon outlines some of the ethical conundrums around embryonic gene editing.…

Save Share

From almost being de-listed by the NASDAQ stock index in 2018 due to poor financial performance, US vaccine firm…

Save Share

Certara’s Ulrich Neumann examines some of the major US market access trends of the past few years, including…

Save Share

Nerum Pharmaceuticals, a Switzerland-based start-up, is supplying high-grade cannabis products to nine countries…

Save Share

Dr Thomas D. Madden, CEO and founder of Acuitas Therapeutics, shares the story behind their involvement in Pfizer…

Save Share

On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…

Save Share

PharmaBoardroom highlights three of the most enterprising and dynamic pharma affiliate country managers working in…

Save Share

During the FT Global Pharmaceutical and Biotechnology Conference last week, GSK global vaccines president Roger…

Save Share

Giorgio Calderari, the chairman of Farma Industria Ticino, the association of chemical and pharmaceutical…

Save Share

The latest from Italian pharma, including the government’s decision to make COVID-19 vaccines mandatory for all…

Save Share

Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park highlights key takeaways from the BIOJapan 2020…

Save Share

Writing in the February edition of DIA’s Global Forum magazine, Xu Wang of Novo Nordisk Pharma China and Xiaoxi…

Save Share

The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi…

Save Share

With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected…

Save Share

In a wide-ranging interview CEO Bertrand Ducrey introduces Debiopharm’s unique business focus on drug…

Save Share

Four companies (GSK, Pfizer, Sanofi, and MSD) together occupy over 80 percent of the global market for vaccines.…

Save Share

Dr Maria T. Millan, president and CEO of the California Institute for Regenerative Medicine (CIRM), shares the…

Save Share

In March 2018, German pharma player Boehringer Ingelheim (BI)‘s Consanas Rehabilitation and the Shanghai…

Save Share

Eric Bouteiller examines the most recent update to China’s National Reimbursement Drug List, the positive impact…

Save Share

When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…

Save Share

Anders Blanck of Lif, the trade association for the research-based Swedish pharmaceutical industry, outlines the…

Save Share

Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the…

Save Share

While Switzerland has Europe’s second-highest proportion of women in the workforce, it trails global…

Save Share

During the FT Global Pharmaceutical and Biotechnology Conference earlier this month, three industry leaders spoke…

Save Share

Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portfolio commercialization, the…

Save Share

COVID-19 has necessitated enormous shifts in the way we live, work, and communicate with each other. Nowhere is…

Save Share

The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L…

Save Share

Janssen Norway’s Mario Klesse shares his first impressions of the Norwegian pharma market, his strategic…

Save Share

Dr Philipp Diesinger and Dr Gabriell Máté outline why a data-driven approach can help optimise patient copay…

Save Share

John-Arne Røttingen, CEO of The Research Council of Norway shares his career journey from academia to industry,…

Save Share

Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of…

Save Share

On 25 November, the European Commission adopted a new strategy meant to, among others, allow Europe to cover its…

Save Share

Writing in the March edition of DIA’s Global Forum magazine, Judith Glennie examines the findings of Health…

Save Share

In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate,…

Save Share